• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    AeroClean Technologies Inc. filed SEC Form 8-K: Other Events

    9/25/23 8:00:11 AM ET
    $AERC
    Environmental Services
    Utilities
    Get the next $AERC alert in real time by email
    0001872356 false 0001872356 2023-09-19 2023-09-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of the
    Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): September 25, 2023 (September 19, 2023)

     

    Molekule Group, Inc.
    (Exact name of registrant as specified in its charter)

     

    Delaware   001-41096   45-3213164
    (State or other jurisdiction
     of incorporation)
      (Commission 
    File Number)
      (IRS Employer
    Identification No.)

     

    10455 Riverside Dr.
    Palm Beach Gardens, FL
      33410
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: (833) 652-5326

     

    Not Applicable

    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e -4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading 
    Symbol(s)
      Name of each exchange on which registered
    Common stock, par value $0.01 per share   MKUL   The Nasdaq Stock Market LLC

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company x

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

     

    Item 8.01 Other Events

     

    On September 19, 2023, the legacy lease landlord, 140 Partners L.P. (the “Landlord”) filed a complaint for breach of lease and declaratory relief (the “Complaint”) against Molekule, Inc. (the “Company”), the subsidiary of Molekule Group, Inc. (“Molekule Group”), in the Superior Court of the State of California for the County of San Francisco under the caption 140 Partners, L.P. vs Molekule, Inc. et al, Case No. CGC-23-609205.

     

    The Complaint alleges that the Company has breached the legacy lease between the Landlord and the Company (the “Lease”) by failing to timely pay monthly rents and other additional fees and interests from May 2023 to September of 2023, in the amount of at least $1,217,877.87. The Landlord drew down the letter of credit (the “LOC”), which was provided by the Company to the Landlord in the amount of $1,673,848.00 as a security pursuant to the Lease, to an amount leaving $1.00 to credit for unpaid rents and other additional fees and interests. The Complaint further alleges that the Company failed to timely deposit cash or reinstate the LOC to the amount of $1,115,898.67 as required under the Lease following the Landlord’s drawdown of the LOC. The Complaint states that there is an actual controversy as to whether the Lease requires the Company to timely deposit sufficient cash or reinstate the LOC to the amount of $1,115,898.67 and whether the Company has breached the Lease for failing to take such actions.

     

    The Complaint seeks, among other forms of relief, for a judgment for the balance of unpaid rent for September 2023 in the sum of $107,576.61, together with any late fees and interest, a declaration that the Lease requires the Company to deposit cash or reinstate the LOC to the amount of $1,115,898.67 and further damages resulting from the Company’s alleged breach of the Lease.

     

    The Landlord has agreed to a litigation standstill on any further action to be taken by it on the Complaint, beyond filing and confirming service on the Company, through October 2, 2023. Following October 2, 2023, the Landlord is free to commence further action against the Company, including, but not limited to, the filing for a writ of attachment against the assets of the Company.

     

    The filing of the Complaint constitutes a breach of a third party agreement that will have a material adverse effect on the business of Molekule, Inc. and an event of default under Molekule Group’s senior and mezzanine loan and security agreements with Silicon Valley Bank (“SVB”). In addition, Molekule Group and the Company have failed to maintain unrestricted and unencumbered cash with SVB of at least $2,000,000, which is also an event of default under the loan agreements. Each such event of default allows SVB to declare that the debt outstanding under the loan agreements has been accelerated and foreclose on Molekule Group’s assets which constitute collateral securing the loan agreements and would prevent Molekule Group and the Company from continuing as a going concern. In addition, the filing of any writ application by the Landlord against the assets of Molekule Group or the Company would result in SVB foreclosing on its security to protect its first priority secured position. The filing of any service of process by the Landlord seeking to attach any funds of Molekule Group or the Company in an amount greater than $100,000, if not cured within 10 days, is also an event of default under the loan agreements with SVB. As previously disclosed, Molekule Group continues to have discussions with SVB in hopes of reaching an agreement prior to making a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code.

     

    Forward-Looking Statements

     

    This Current Report on Form 8-K contains “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based upon current beliefs and expectations of our management and are subject to known and unknown risks and uncertainties. Words or expressions such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “estimates,” “may,” “will,” “projects,” “could,” “should,” “would,” “seek,” “forecast” or other similar expressions help identify forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and actual results may differ materially from those in the forward-looking statements as a result of various factors. Although Molekule Group believes that the expectations reflected in the forward-looking statements are reasonable based on information currently available, Molekule Group cannot assure you that the expectations will prove to have been correct. Accordingly, you should not place undue reliance on these forward-looking statements. In any event, these statements speak only as of the date of this Current Report on Form 8-K. The parties undertake no obligation to revise or update any of the forward-looking statements to reflect events or circumstances after the date of this Current Report on Form 8-K or to reflect new information or the occurrence of unanticipated events.

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     MOLEKULE GROUP, INC.
      
    Dated: September 25, 2023By: /s/ Ryan Tyler
       Name: Ryan Tyler 
       Title: Chief Financial Officer

     

     

    Get the next $AERC alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $AERC

    DatePrice TargetRatingAnalyst
    6/14/2022Buy → Hold
    The Benchmark Company
    2/1/2022Speculative Buy
    Benchmark
    More analyst ratings

    $AERC
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AeroClean Technologies and Molekule Announce the Close of All-Stock Merger

      Establishes an industry-leading provider of premium, FDA-cleared air purification products and solutionsPositions the combined company to selectively pursue additional value-creating M&A opportunities within the broader indoor air quality ("IAQ") and cleantech industriesPowerful brand value and large installed base of over 350,000 air purification units creates an opportunity to drive recurring revenues through consumables and the launch of a software solution to monitor and control air quality on an enterprise-wide basisRecent developments include the release of Molekule's PECO-HEPA Tri-Power Filter for Air Pro, Air Mini+ and Air Mini; AeroClean's Pūrgo™ air purifier receiving FDA clearance

      1/12/23 9:00:00 AM ET
      $AERC
      Environmental Services
      Utilities
    • AeroClean's Pūrgo™ Air Purifier Receives FDA Clearance for the Elimination of SARS-CoV-2

      Additional Testing Being Performed to Confirm Elimination of Influenza and RSV PALM BEACH GARDENS, Fla., Dec. 07, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a leading air hygiene technology company, today announced that, the U.S. Food and Drug Administration ("FDA") has granted AeroClean 510k clearance (K223328) to update its Pūrgo™ air purifier's ("Pūrgo™") indications for use to include the elimination of SARS-CoV-2, the RNA virus that causes COVID-19. The FDA has reviewed the laboratory performance data and confirmed the applicability of Pūrgo to remove SARS-CoV-2 from the air in indoor environments. The clearance adds SARS-CoV-2 to th

      12/7/22 8:36:24 AM ET
      $AERC
      Environmental Services
      Utilities
    • AeroClean Reports Third Quarter 2022 Financial Results

      PALM BEACH GARDENS, Fla., Nov. 14, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a leading air hygiene technology company, today reported financial results for the three and nine months ended September 30, 2022 ("Q3 2022"). Third Quarter 2022 Highlights and Recent Developments The Company entered into a definitive agreement with Molekule, Inc. ("Molekule"), a market leader for premium air purifiers, to combine in an all-stock merger that the Company believes will establish a combined company as a market leader for premium, FDA-cleared air purification products, and solutions.Molekule recently began collaboration with key customers across th

      11/14/22 8:55:00 AM ET
      $AERC
      Environmental Services
      Utilities

    $AERC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Dibona Jason

      4 - Molekule Group, Inc. (0001872356) (Issuer)

      5/17/23 4:17:27 PM ET
      $AERC
      Environmental Services
      Utilities
    • SEC Form 4 filed by Tyler Ryan

      4 - Molekule Group, Inc. (0001872356) (Issuer)

      5/17/23 4:15:43 PM ET
      $AERC
      Environmental Services
      Utilities
    • SEC Form 4 filed by Khoury Amin J

      4 - Molekule Group, Inc. (0001872356) (Issuer)

      4/20/23 7:57:21 PM ET
      $AERC
      Environmental Services
      Utilities

    $AERC
    SEC Filings

    See more
    • SEC Form 25-NSE filed by AeroClean Technologies Inc.

      25-NSE - Molekule Group, Inc. (0001872356) (Subject)

      11/20/23 8:46:42 AM ET
      $AERC
      Environmental Services
      Utilities
    • AeroClean Technologies Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Molekule Group, Inc. (0001872356) (Filer)

      10/4/23 8:47:38 PM ET
      $AERC
      Environmental Services
      Utilities
    • AeroClean Technologies Inc. filed SEC Form 8-K: Bankruptcy or Receivership, Creation of a Direct Financial Obligation, Events That Accelerate or Increase a Direct Financial Obligation, Regulation FD Disclosure

      8-K - Molekule Group, Inc. (0001872356) (Filer)

      10/3/23 3:25:23 PM ET
      $AERC
      Environmental Services
      Utilities

    $AERC
    Leadership Updates

    Live Leadership Updates

    See more
    • AeroClean Announces Appointment of Jimmy Thompson as Vice President of Strategic Sales

      Healthcare Technology Expert To Lead Targeted Sales Efforts For FDA-Cleared Germicidal UV-C Air Hygiene Technology PALM BEACH GARDENS, Fla., June 08, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a leading air hygiene technology company and producer of patented UV-C LED technology inside its innovative Pūrgo™ air purification device, announces Jimmy Thompson has joined the Company as Vice President of Strategic Sales. The addition of Thompson to the AeroClean team is a strategic investment to support core business and revenue growth within targeted industry verticals. Along with driving sales initiatives, Thompson will also be focused on dev

      6/8/22 8:00:00 AM ET
      $AERC
      Environmental Services
      Utilities
    • AeroClean Announces Appointment of Timothy J. Scannell to Board of Directors

      PALM BEACH GARDENS, Fla., May 12, 2022 (GLOBE NEWSWIRE) -- AeroClean Technologies ("AeroClean" or the "Company") (NASDAQ:AERC), a pathogen elimination technology company harnessing patented UV-C LED technology with Pūrgo™ to significantly reduce and remove harmful pathogens to keep work, play and life going, today announced the appointment of Timothy J. Scannell, former President and Chief Operating Officer at Stryker, to its Board of Directors (the "Board"). On May 11, 2022, the Board appointed Mr. Scannell as a new director on the Board, chair of the Nominating and Corporate Governance Committee and a member of the Compensation Committee. Mr. Scannell brings over 30 years of experienc

      5/12/22 1:00:00 PM ET
      $AERC
      $NVCR
      $PODD
      $RNLX
      Environmental Services
      Utilities
      Medical/Dental Instruments
      Health Care

    $AERC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by AeroClean Technologies Inc. (Amendment)

      SC 13G/A - Molekule Group, Inc. (0001872356) (Subject)

      2/13/24 9:47:51 PM ET
      $AERC
      Environmental Services
      Utilities
    • SEC Form SC 13G/A filed by AeroClean Technologies Inc. (Amendment)

      SC 13G/A - Molekule Group, Inc. (0001872356) (Subject)

      2/8/23 4:18:36 PM ET
      $AERC
      Environmental Services
      Utilities
    • SEC Form SC 13G/A filed by AeroClean Technologies Inc. (Amendment)

      SC 13G/A - Molekule Group, Inc. (0001872356) (Subject)

      2/8/23 4:17:30 PM ET
      $AERC
      Environmental Services
      Utilities

    $AERC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • AeroClean Technologies downgraded by The Benchmark Company

      The Benchmark Company downgraded AeroClean Technologies from Buy to Hold

      6/14/22 7:14:46 AM ET
      $AERC
      Environmental Services
      Utilities
    • Benchmark initiated coverage on AeroClean Technologies

      Benchmark initiated coverage of AeroClean Technologies with a rating of Speculative Buy

      2/1/22 12:29:46 PM ET
      $AERC
      Environmental Services
      Utilities

    $AERC
    Financials

    Live finance-specific insights

    See more
    • AeroClean Technologies and Molekule to Combine in an All-Stock Merger Establishing an Industry-Leading Provider of Premium, FDA-Cleared Air Purification Products and Solutions

      Transaction Highlights Creates a pro forma company with a substantial base of revenues, a solid balance sheet and a path to profitability.A broad range of highly complementary, proprietary and patented, FDA-cleared air purification devices.Powerful brand value and recognition with an installed base of over 350,000 air purification units, providing a foundation for growing recurring revenues from both consumables and the launch of a SaaS software solution to enable facility managers to monitor and control individual room air quality on an enterprise wide basis.Expected double-digit organic revenue growth for the combined company, with gross profit expected to grow faster than revenues due to

      10/3/22 4:15:00 PM ET
      $AERC
      Environmental Services
      Utilities